共 132 条
[1]
Frick M.H.(2001)Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2486-97
[2]
Elo O.(1984)The lipid research clinics coronary primary prevention trial results: I. Reduction in the incidence of coronary heart disease JAMA 251 351-64
[3]
Happa K.(1984)The lipid research clinics coronary primary prevention trial results: II. The relationship of reduction in the incidence of coronary heart disease to cholesterol-lowering JAMA 251 365-74
[4]
Sacks F.M.(1987)Helsinki Heart Study: primary-prevention with gemfibrozil in middle-aged men with dyslipidemia N Engl J Med 317 1237-45
[5]
Pfeffer M.A.(1994)Randomised trial of cholesterol lowering in 4 444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1383-9
[6]
Moy L.A.(1996)for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1001-9
[7]
Tonkin A.(1998)Prevention of cardiovascular events and deaths with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med 339 1349-57
[8]
Aylward P.(1995)Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1301-7
[9]
Colqhoun D.(1998)for the AFCAPS/ TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS JAMA 279 1615-22
[10]
Shepherd S.(2002)MRC/BFH Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 7-22